• <em>FCGR3A</em> F158V alleles frequency differs in multiple myeloma patients from healthy population
• A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience
• A diagnostic pitfall due to lymphoplasmacytic morphology in plasma cell leukemia
• A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples
• A rare presentation of spontaneous splenic rupture from plasma cell leukaemia-a case report
• A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target
• Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications
• Additional considerations in cancer cell radioresistance, integrin alphavbeta3 and thyroid hormones
• Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
• Ankrd26 is a retinoic acid-responsive plasma membrane-binding and -shaping protein critical for proper cell differentiation
• Anti-allergic effect of vitamin C through inhibiting degranulation and regulating T(H) 1/T(H) 2 cell polarization
• Application and pitfalls of immunophenotyping in challenging plasma cell neoplasms: a case series
• ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
• Bee Venom: Composition and Anticancer Properties
• Biallelic variation in the choline and ethanolamine transporter <em>FLVCR1</em> underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders
• Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
• BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models
• CAR-T Cell Therapy for T-Cell Malignancies
• CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence
• Cell-intrinsic mechanical regulation of plasma membrane accumulation at the cytokinetic furrow
• Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group
• Chinese expert consensus on the application of flow cytometry for the detectin of circulating plasma cells in plasma cell disorders (2024)
• Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
• Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
• Combination p53 activation and BCL-x(L)/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
• Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies
• Comparison of plasma and blood cell samples in metagenomic next-generation sequencing for identification of the causative pathogens of fever
• Complete Rescue of HTLV-1_p12KO Infectivity by Depletion of Monocytes Together with NK and CD8⁺ T Cells
• Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients
• Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis
• Coumarin-based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors
• Current Status on Management of Primary Plasma Cell Leukemia
• Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity
• Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation
• Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
• Diagnosis of Cutaneous Acute Graft-Versus-Host Disease Through Circulating Plasma miR-638, miR-6511b-5p, miR-3613-5p, miR-455-3p, miR-5787, and miR-548a-3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation
• Dual targeting of glutamine and serine metabolism in acute myeloid leukemia
• Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
• Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
• Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
• EXPRESS: A new therapeutic perspective: erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes
• Expression, Function, and Significance of Non B Cell-Derived Immunoglobulin in Haematological System
• Functional characterization of native Piezo1 as calcium and magnesium influx pathway in human myeloid leukemia cells
• Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasms - a practical guide to WHO HAEM5
• Genomic technologies for detecting structural variations in hematologic malignancies
• Hairy cell leukemia with plasmacytoid morphology
• Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
• Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice
• Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing
• Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
• Identification of a novel monocyte/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia
• Identifying a core protein signature of small extracellular vesicles derived from B-cell precursor acute lymphoblastic leukaemia
• IL-18-secreting multi-antigen targeting CAR T-cells eliminate antigen-low myeloma in an immunocompetent mouse model
• Improved Outcome of Primary Plasma Cell Leukemia in the Current Era with the Use of Novel Agents and Autologous Bone Marrow Transplants-A Single Centre Experience
• In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry
• Interpreting single-cell messages in normal and aberrant hematopoiesis with the Cell Marker Accordion
• Koji Mold-derived Lipids Disrupt the Intracellular Redox State by Decreasing the GPx4 and Intracellular Glutathione Levels, Promoting Membrane Lipid Peroxidation, and Inducing Ferroptosis in HL-60 Cells
• Liquid-liquid phase separation in subcellular assemblages and signaling pathways: Chromatin modifications induced gene regulation for cellular physiology and functions including carcinogenesis
• Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification
• Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study
• Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia
• Multiple cancer cell types release LIF and Gal3 to hijack neural signals
• Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics
• Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies
• New insights into the mechanisms regulating plasma cell survival and longevity
• Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization
• Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
• Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review
• Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia
• Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia
• Post-transplant de novo anti-HLA donor specific antibodies may contribute to poor graft function after haploidentical haematopoietic stem cell transplantation
• Primary plasma cell leukaemia in a 22-year-old woman: A case report
• Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria
• Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
• Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model
• Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study
• Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells
• Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
• Secondary plasma cell leukaemia (PCL) with plasmablastic morphology
• Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry
• Simultaneous Purification of Human Interferon Alpha-2b and Serum Albumin Using Bioprivileged Fluorinated Ionic Liquid-Based Aqueous Biphasic Systems
• Single-center experience of patients with plasma cell leukemia in the era of new therapeutics
• SLPI overexpression in hMSCs could be implicated in the HSC gene expression profile in AML
• Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma
• Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma
• Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting
• SWIGH-SCORE: A translational light-weight approach in computational detection of rearranged immunoglobulin heavy chain to be used in monoclonal lymphoproliferative disorders
• Synergistic pathogenicity of vertically transmitted chicken infectious anemia virus and avian leukosis virus subgroup J coinfection in chickens
• Targeted lipidomics-based study of radiation-induced metabolite profiles changes in plasma of total body irradiation cases
• Targeted Metabolomics of Tissue and Plasma Identifies Biomarkers in Mice with NOTCH1-Dependent T-Cell Acute Lymphoblastic Leukemia
• The 507th case: hemolytic anemia, parvovirus B19, and multiple organ dysfunction
• The effect of inflammatory cytokines on the risk of hypertrophic scar: a mendelian randomization study
• The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)
• The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
• Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia
• Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib
• Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
• Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review
• Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression
• Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts-implications for acute myeloid leukaemia